Rita De Gasperi
- ASSOCIATE PROFESSOR Psychiatry
Role of presenilin-1 in cortical and vasculardevelopment and AD pathogenesis
Transgenic models of AD
In vivo marking of neural stem cells with fluorescent proteins
Neurovascular interactions in development and disease
De Gasperi R, Gama Sosa MA, Wen PH, Li J, Perez GM, Curran T, Elder GA. Cortical development in the presenilin-1 null mutant mouse fails after splitting of the preplate and it is not due to a failure of reelin dependent signaling. Developmental Dynamics 2008; 237: 2405-2413.
De Gasperi R, Rocher AB, Gama Sosa MA, Wearne SL, Perez GM. The IRG Mouse: A Two-Color Fluorescent Reporter for Assessing Cre-Mediated Recombination and Imaging Complex Cellular Relationships In Situ. Genesis 2008; 46: 308-317.
Gama Sosa MA, De Gasperi R, Rocher AB, Perez GM, Simons K, Cruz DE, Hof PR, Elder GA. Interactions of primary neuroepithelial progenitor and brain endothelial cells: distinct effect on neural progenitor maintenance and differentiation by soluble factors and direct contact. Cell Research 2007; 17: 619-626.
Franciosi S, De Gasperi R, Dickstein DL, English DF, Rocher AB, Janssen WM, Christoffel D, Gama Sosa MA, Hof PR, Buxbaum JD, Elder GA. Pepsin Pretreatment Allows Collagen IV Immunostaining of Blood Vessels in Adult Mouse Brain. Journal of Neuroscience Methods 2007; 163: 76-82.
Wen PH, De Gasperi R, Gama Sosa MA, Rocher AB, Friedrich VL Jr., Hof PR, Elder GA. Selective expression of presenilin-1 in neural progenitor cells rescues the cerebral hemorrhages and cortical lamination defects in presenilin-1 null mutant mice. Development 2005; 132: 3873-3883.
Gama Sosa MA, Wen PH, De Gasperi R, Perez G, Senturk E, Friedrich VL Jr., Elder GA. Entorhinal Cortex Lesioning Promotes Neurogenesis in the Hippocampus of Adult Mice. Neuroscience 2004; 127: 881-891.
Wen PH, De Gasperi R, Gama Sosa MA, Elder GA. Neural progenitor cells do not differentiate prematurely in presenilin 1 null mutant mice. Neuroscience Letters 2004; 371: 249-254.
Wen PH, Hof PR, Chen X, Gluck K, Austin G, Younkin SG, Younkin LH, De Gasperi R, Gama Sosa MA, Robakis NK, Haroutunian V, Elder GA. The presenilin-1 familial Alzheimer disease mutant P117L impairs neurogenesis in the hippocampus of adult mice. Experimental Neurology 2004; 188: 224-237.
De Gasperi R, Friedrich VL, Perez GM, Senturk E, Wen PH, Kelley K, Elder GA, Gama Sosa MA. Transgenic rescue of the twitcher mouse. Gene Therapy 2004; 11: 1188-1194.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. De Gasperi did not report having any of the following types of financial relationships with industry during 2013 and/or 2014: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
James J Peters Veteran Adminis Floor 3F Room 20
130 West Kingsbridge Road
Bronx, NY 10468